U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.
1 minute read
Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology
Tags:
Related News
Beans, meal and oil: how to calculate a gross soybean crush spread, check units, and distinguish a board comparison from
- October 20, 2026
This article delves into how AI in commodity trading is projected to deliver an average additional 3.34% in trading P&L
- October 20, 2026
Listen to Odd Lots on Apple PodcastsListen to Odd Lots on SpotifyWatch Odd Lots on YouTubeSubscribe to the newsletter
- October 20, 2026
The Commodity Futures Trading Commission was practically brand new when Terry Duffy started working at CME Group almost five decades
- October 20, 2026
Read MoreCommodities & Futures News
- October 20, 2026
Anna Edwards, Guy Johnson, and Paul Dobson break down today’s key themes for analysts and investors on “Bloomberg: The Opening
- October 20, 2026
Stay Ahead of Market Moves
Get our daily commodity market analysis delivered to your inbox. Join 5,000+ traders who trust our insights.
No spam. Unsubscribe anytime. 2x weekly digests.
Related Guides
Popular Articles
24k views
18K views
15K views